How should I evaluate and treat a patient with a serum sodium of 132 mEq/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Serum Sodium 132 mEq/L

Initial Assessment

A serum sodium of 132 mEq/L represents mild hyponatremia that warrants evaluation but typically does not require aggressive intervention unless symptoms are present. 1

Determine Clinical Context

  • Assess symptom severity: Mild hyponatremia (130-135 mEq/L) may cause nausea, vomiting, weakness, headache, or mild cognitive deficits, though many patients remain asymptomatic 2, 3
  • Establish chronicity: Determine whether onset is acute (<48 hours) or chronic (>48 hours), as acute hyponatremia causes more severe symptoms at the same sodium level 2, 4
  • Evaluate volume status: Perform physical examination looking specifically for orthostatic hypotension, dry mucous membranes, decreased skin turgor (hypovolemia), or peripheral edema, ascites, jugular venous distention (hypervolemia) 1

Essential Laboratory Workup

Order serum and urine osmolality, urine sodium concentration, serum creatinine, and thyroid-stimulating hormone to determine the underlying cause. 1

  • Serum osmolality distinguishes true hypotonic hyponatremia from pseudohyponatremia 1
  • Urine osmolality <100 mOsm/kg suggests appropriate ADH suppression; >100 mOsm/kg indicates impaired water excretion 1
  • Urine sodium <30 mmol/L suggests hypovolemic hyponatremia with 71-100% positive predictive value for saline responsiveness 1
  • Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 1

Treatment Algorithm Based on Volume Status

For Hypovolemic Hyponatremia (Urine Na <30 mmol/L, signs of volume depletion)

Administer isotonic saline (0.9% NaCl) for volume repletion at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on clinical response. 1

  • Discontinue any diuretics contributing to sodium loss 1
  • Target correction rate of 4-8 mEq/L per day, never exceeding 8 mEq/L in 24 hours 1
  • Monitor serum sodium every 4-6 hours during active correction 1

For Euvolemic Hyponatremia (SIADH suspected)

Implement fluid restriction to 1 L/day as first-line therapy. 1, 5

  • If no response to fluid restriction after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1
  • Consider vasopressin receptor antagonists (tolvaptan 15 mg once daily) for resistant cases, though this is rarely needed at sodium 132 mEq/L 1, 6
  • Avoid fluid restriction in neurosurgical patients where cerebral salt wasting is possible 1

For Hypervolemic Hyponatremia (Heart failure, cirrhosis)

At sodium 132 mEq/L in hypervolemic states, continue current diuretic therapy with close electrolyte monitoring; fluid restriction is not yet indicated. 1

  • Fluid restriction to 1-1.5 L/day is reserved for sodium <125 mEq/L 1
  • For cirrhotic patients, consider albumin infusion alongside fluid management 1
  • Avoid hypertonic saline unless life-threatening symptoms develop 1

Correction Rate Guidelines and Safety

The absolute maximum correction is 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome. 1, 4

  • Target 4-6 mEq/L per day for high-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy) 1
  • Monitor for signs of osmotic demyelination syndrome 2-7 days after correction: dysarthria, dysphagia, oculomotor dysfunction, quadriparesis 1
  • If overcorrection occurs, immediately administer D5W or desmopressin to relower sodium 1

Special Considerations

Medication Review

Evaluate all medications for potential causes, particularly SSRIs, carbamazepine, NSAIDs, diuretics, and chemotherapy agents. 1, 7

  • Drug-induced hyponatremia often resolves with discontinuation and water restriction 7
  • Trazodone and other antidepressants place patients at particularly high risk 1

High-Risk Populations

  • Cirrhotic patients: Even mild hyponatremia indicates worsening hemodynamic status and increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
  • Elderly patients: Advanced age is associated with increased risk of hyponatremia and its complications 7
  • Neurosurgical patients: Distinguish between SIADH and cerebral salt wasting, as treatments are opposite 1

Common Pitfalls to Avoid

  • Do not ignore mild hyponatremia (130-135 mEq/L) as clinically insignificant—it increases fall risk 4-fold (21% vs 5%) and mortality 60-fold (11.2% vs 0.19%) when sodium <130 mEq/L 1, 2
  • Do not apply aggressive fluid restriction at sodium 132 mEq/L unless SIADH is confirmed and symptomatic 1
  • Do not use hypertonic saline for asymptomatic mild hyponatremia—reserve for severe symptoms (seizures, coma, altered consciousness) 1, 3
  • Do not correct faster than 8 mEq/L in 24 hours regardless of initial sodium level 1, 8

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyponatremia Symptoms and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of Severe Hyponatremia.

Clinical journal of the American Society of Nephrology : CJASN, 2018

Research

[Hyponatremia].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013

Research

Causes and management of hyponatremia.

The Annals of pharmacotherapy, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.